NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









NVision

NVision

Private
UlmHealthcare & Life Scienceshttps://www.nvision-quantum.com/

Last Round

Debt

May 13, 2026

Total Funding Raised

$71.5M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

NVision is a quantum technology company that develops quantum-enhanced MRI sensing platforms and photonic integrated quantum circuits for healthcare and drug discovery applications.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Quantum Computing, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

quantum sensingmetabolic MRIhyperpolarizationquantum hardwaremedical imagingdrug discoveryphotonic integrated quantum circuitsPIQCmolecular quantum systemsquantum techdeep techbiotech equipmentdiagnostic imagingquantum computinglab tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NVision Comps

Public and private peers based on sector, stage, and business model.

NVision comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

NVision Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtMay 13, 2026
GrantJun 22, 2023
Series AJun 22, 2023

NVision Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 13, 2026

    $17M round led by Abbott Laboratories

  • Feb 18, 2026

    Grew 33% quarter-over-quarter, from 12 to 16 employees.

NVision Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NVision Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NVision's valuation, stock price, and market status.

Firmographic Details

HeadquartersUlm
Employee Range19
Year Founded2015
Last FundingMay 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.